Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
Juliane ReichenbachPatricia FraungruberDoris MayrChristina BuschmannFabian B T KrausNicole Elisabeth TopalovAnca Chelariu-RaicuThomas KolbenAlexander BurgesSven MahnerMirjana KesslerUdo JeschkeBastian CzogallaFabian TrillschPublished in: Journal of cancer research and clinical oncology (2023)
Our results support the hypothesis that nuclear co-repressors such as NCOR2 may influence the transcription of target genes in EOC such as GPER. Understanding the role of nuclear co-repressors on signaling pathways will allow a better understanding of the factors involved in prognosis and clinical outcome of EOC patients.